iCAD, Inc. (ICAD)

NASDAQ: ICAD · IEX Real-Time Price · USD
1.610
+0.010 (0.63%)
At close: Mar 28, 2024, 4:00 PM
1.530
-0.080 (-4.97%)
After-hours: Mar 28, 2024, 6:49 PM EDT

Company Description

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States.

It operates through two segments, Cancer Detection and Cancer Therapy. The company's breast AI suite includes cancer detection, automated density assessment, and breast cancer risk assessment solutions for both 2D and 3D mammography.

It offers PowerLook, a back-end architecture platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm that analyzes 2D full-field digital mammography images to identify and mark suspicious masses and calcifications; and PowerLook Density Assessment provides automated, consistent, and standardized breast density assessments.

The company also offers ProFound AI, a deep-learning algorithm designed to detect malignant soft-tissue densities and calcifications in digital breast tomosynthesis; ProFound AI Risk, a clinical decision support tool that provides breast cancer risk estimation based on a screening mammogram; and VeraLook, a solution designed to support detection of colonic polyps in conjunction with Computed Tomography Colonography.

In addition, it offers Xoft Axxent electronic brachytherapy systems for the treatment of early-stage breast, non-melanoma skin, and gynecological cancers to university research and community hospitals, cancer care clinics, veterinary facilities, and dermatology offices.

The company sells its products through direct sales organizations, as well as through various original equipment manufacturer partners, distributors, technology platform partners, and resellers.

It also exports its products in Europe, Taiwan, Canada, China, and internationally. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002.

iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

iCAD, Inc.
iCAD, Inc. logo
Country United States
Founded 1984
IPO Date Dec 3, 1986
Industry Medical Devices
Sector Healthcare
Employees 108
CEO Ms. Dana R. Brown

Contact Details

Address:
98 Spit Brook Road, Suite 100
Nashua, New Hampshire 03062
United States
Phone 603-882-5200
Website icadmed.com

Stock Details

Ticker Symbol ICAD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000749660
CUSIP Number 44934S206
ISIN Number US44934S2068
Employer ID 02-0377419
SIC Code 3841

Key Executives

Name Position
Dana R. Brown President, Chief Executive Officer and Executive Chair
Jonathan Go Chief Technology Officer
Eric Lonnqvist Chief Financial Officer
Michelle Strong Chief Operations Officer
Annette L. Heroux Vice President of Administration
Anthony Takazawa Director of Investor Relations
Brian Testa Chief People Officer
Bill Keyes Senior Vice President of Global Sales Operations
Vasu Avadhanula Chief Product Officer
Peter Graham Senior Vice President of North American Sales

Latest SEC Filings

Date Type Title
Mar 12, 2024 8-K Current Report
Feb 26, 2024 8-K Current Report
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 25, 2024 8-K Current Report
Dec 28, 2023 144 Filing
Nov 14, 2023 10-Q Quarterly Report
Nov 13, 2023 8-K Current Report
Nov 7, 2023 8-K Current Report
Oct 23, 2023 8-K Current Report
Aug 14, 2023 8-K Current Report